Curevac N.V. buy sailamac
Start price
09.02.21
/
95%
€95.29
Target price
09.02.22
€145.00
Performance (%)
-62.48%
End price
05.11.21
€35.76
Summary
This prediction ended on 05.11.21 with a price of €35.76. Massive losses of -62.48% were the result for the BUY prediction by sailamac. sailamac has 95% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Curevac N.V. | 5.450% | 5.450% | - | - |
iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
According to sailamac what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Very capable Management
Leading role in innovation
Some uniques
Growths much faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Stable Large shareholder and/or long term investor
Cons
Risky Investment
Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued
Comments by sailamac for this prediction
In the thread Curevac N.V. diskutieren
Buy mit Kursziel 120,0
Kursziel geändert auf 14,0
Kursziel geändert auf 1.140,0
Kursziel geändert auf 140,0
https://www.onvista.de/news/3-tolle-impfstoff-news-von-der-biontech-aktie-curevac-aktie-und-johnson-johnson-aktie-435435773
Kursziel geändert auf 145,0
In the thread Trading Curevac N.v.
Buy beendet
Stopped prediction by sailamac for Curevac N.V.
Curevac N.V.
Start price
Target price
Perf. (%)
€35.76
05.11.21
05.11.21
€1.00
09.02.22
09.02.22
-53.33%
10.02.22
10.02.22
Very capable Management
Leading role in innovation
Some uniques
Growths much faster than the competition